Table 1.
EBV Laboratory Results for the Study Subjects.
| EBV Test | Acute EBV (N = 46) | Chronic Active EBV (N = 9) | Healthy Control (N = 55) |
|---|---|---|---|
| EBV VCA-IgM (# positive) | 46 | 0 | 0 |
| Primary cohort | 6 | 0 | 0 |
| Secondary cohort | 40 | 0 | 0 |
| EBV VCA-IgG (# positive) | 38 | 9 | 48 |
| Primary cohort | 6 | 5 | 6 |
| Secondary cohort | 32 | 4 | 42 |
| EBV ENA-lgG (# positive) | 0 | 8 | 47 |
| Primary cohort | 0 | 5 | 4 |
| Secondary cohort | 0 | 3 | 43 |
| EBV DNA load in plasma [#; range; median (copies/ml blood)] | 19; 1020~48300; 3280 | 9; 3440~1460000; 53200 | ND |
| Primary cohort | 3; 3680~13400; 10300 | 5; 3440~1460000; 36000 | ND |
| Secondary cohort | 16; 1020~48300; 3350 | 4; 5840~202000; 29765 | ND |
| EBV DNA load in WBC [#; range; median (copies/ml blood)] | 40; 1190~3760000; 40950 | ND | ND |
| Primary cohort | 4; 2380~513000; 55290 | ND | ND |
| Secondary cohort | 36; 1190~3760000; 40950 | ND | ND |
Note: ND –not determined.